KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
CMOs showed an increasing reluctance to take on debt in 2022
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Advances clinical research capabilities with leading regulatory grade registries platform
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Subscribe To Our Newsletter & Stay Updated
